MolNFT v1 · #102052 · protein
Crystal structure of a gnat superfamily acetyltransferase PA4794 in complex with chloramphenicol
4OAD: “Crystal structure of a gnat superfamily acetyltransferase PA4794 in complex with chloramphenicol”. X-ray diffraction, 2 ligands (CLM, SO4), 1 pocket (best druggability 0.68). MolNFT v1 #102052 on GenesisL1: 3D structure, binding…
- PDB
- 4OAD
- Type
- protein
- Length
- 160 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Gnat superfamily acetyltransferase PA4794
- UniProt
- Q9HV14
- Ligands
- CLM, SO4
- Pockets
- 1 · best druggability 0.68
Structure
x-ray diffraction · 1 distinct chain · 34% helix, 37% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Gnat superfamily acetyltransferase PA4794 | protein | 160 | 34% helix, 37% strand | Q9HV14 |
Ligands and binding sites
- CLM · Chloramphenicol · ligand · 2 copies · chains A
- SO4 · Sulfate ion · ion · 4 copies · chains A
- EDO · 1,2-ethanediol · additive · 8 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 302 | 0.68 | 0.82 | 37 | SO4, CLM, EDO |
Compared structures
- 4OAD · Crystal structure of a GNAT superfamily acetyltransferase PA4794 in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9HV14
- Elsewhere: RCSB PDB 4OAD · PDBe 4OAD · UniProt Q9HV14
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.